Pharmacological relapse prevention in alcohol and tobacco dependence;Pharmakologische rückfallprävention bei alkohol- und tabakabhängigkeit

Internist

Volumn 48, Issue 1, 2007, Pages 79-88

  Diehl, A ^a   Mann, K ^a  

^a CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

Alcohol dependence; Craving; Nicotine; Relapse prevention; Tobacco dependence

Indexed keywords

ACAMPROSATE; ALCOHOL; AMFEBUTAMONE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BUSPIRONE; CARBAMAZEPINE; CITALOPRAM; DISULFIRAM; DOXEPIN; FLUOXETINE; FLUPENTIXOL; MOCLOBEMIDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NALMEFENE; NALTREXONE; NEFAZODONE; NICOTINE DERIVATIVE; NICOTINE GUM; NICOTINE PATCH; NORTRIPTYLINE; ONDANSETRON; OPIATE ANTAGONIST; PLACEBO; RITANSERIN; SEROTONIN 1A ANTAGONIST; SEROTONIN 3 ANTAGONIST; SERTRALINE; TOPIRAMATE; UNINDEXED DRUG;

ABSTINENCE; ALCOHOLISM; ARTICLE; DETOXIFICATION; DRUG EFFICACY; GERMANY; HUMAN; NEUROBIOLOGY; OUTCOME ASSESSMENT; PSYCHOPHARMACOTHERAPY; PSYCHOSOCIAL CARE; TOBACCO DEPENDENCE; TREATMENT DURATION; TREATMENT OUTCOME;

ALCOHOL DETERRENTS; ALCOHOLISM; CLINICAL TRIALS AS TOPIC; COMBINED MODALITY THERAPY; DISULFIRAM; HUMANS; NALTREXONE; NICOTINE; PSYCHOTHERAPY; RECURRENCE; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME; TAURINE; TOBACCO USE DISORDER;

EID: 33846649466     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00108-006-1755-z     Document Type: Article

References (31)

1. Mann K, Schafer DR, Langle G et al. (2005) The long-term course of alcoholism, 5, 10 and 16 years after treatment. Addiction 100: 797-805
2. Project MATCH Research Group (1998) Matching alcoholism treatments to client heterogeneity: Project MATCH three-year drinking outcomes. Alcohol Clin Exp Res 22: 1300-1311
3. Mann K (2004) Pharmacotherapy of alcohol dependence: a review of the clinical data. CNS Drugs 18: 485-504
4. Anton RF, O'Malley SS, Ciraulo DA et al. (2006) Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA 295: 2003-2017
5. Fuller RK, Branchey L, Brightwell DR et al. (1986) Disulfiram treatment of alcoholism. A Veterans Administration cooperative study. JAMA 256: 1449-1455
6. Ehrenreich H, Jahn H, Heutelbeck K et al. (2002) ALITA - Neue Wege in der ambulanten Intensivbehandlung von Alkoholabhängigen. In: Mann KF (Hrsg) Neue Therapieansätze bei Alkoholproblemen. Pabst, Lengerich, pp 145-160
7. Anton RF, Moak DH, Waid LR et al. (1999) Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial. Am J Psychiatry 156: 1758-1764
8. Chick J, Howlett H, Morgan MY et al. (2000) United Kingdom Multicentre Acamprosate Study (UKMAS): a 6-month prospective study of acamprosate versus placebo in preventing relapse after withdrawal from alcohol. Alcohol Alcohol 35: 176-187
9. Gastpar M, Bonnet U, Boning J et al. (2002) Lack of efficacy of naltrexone in the prevention of alcohol relapse: results from a German multicenter study. J Clin Psychopharmacol 22: 592-598
10. Kiefer F, Jahn H, Tarnaske T et al. (2003) Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study. Arch Gen Psychiatry 60: 92-99
11. Krystal JH, Cramer JA, Krol WF et al. (2001) Naltrexone in the treatment of alcohol dependence. N Engl J Med 345: 1734-1739
12. O'Malley SS, Jaffe AJ, Chang G et al. (1992) Naltrexone and coping skills therapy for alcohol dependence: a controlled study. Arch Gen Psychiatry 49: 881-887
13. Garbutt JC, West SL, Carey TS et al. (1999) Pharmacological treatment of alcohol dependence: a review of the evidence. JAMA 281: 1318-1325
14. Balldin J, Berglund M, Borg S et al. (2003) A 6-month controlled naltrexone study: combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependence. Alcohol Clin Exp Res 27: 1142-1149
15. Heinala P, Alho H, Kiianmaa K et al. (2001) Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: a factorial double-blind, placebo-controlled trial. J Clin Psychopharmacol 21: 287-292
16. Srisurapanont M, Jarusuraisin N (2005) Naltrexone for the treatment of alcoholism: a meta-analysis of randomized controlled trials. Int J Neuropsychopharmacol 8: 267-280
17. Gual A, Lehert P (2001) Acamprosate during and after acute alcohol withdrawal: a double-blind placebo-controlled study in Spain. Alcohol Alcohol 36: 413-418
18. Sass H, Soyka M, Mann K et al. (1996) Relapse prevention by acamprosate: results from a placebo-controlled study on alcohol dependence. Arch Gen Psychiatry 53: 673-680
19. Di Chiara G (2000) Role of dopamine in the behavioural actions of nicotine related to addiction. Eur J Pharmacol 393: 295-3141
20. Picciotto MR, Zoli M, Rimondini R et al. (1998) Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature 391: 173-177
21. Dani JA, Radcliffe KA, Pidoplichko VI (2000) Variations in desensitization of nicotinic acetylcholine receptors from hippocampus and midbrain dopamine areas. Eur J Pharmacol 393: 31-38
22. Olausson P, Jentsch JD, Taylor JR (2004) Nicotine enhances responding with conditioned reinforcement. Psychopharmacology 171: 173-178
23. Smolka MN, Buhler M, Klein S et al. (2006) Severity of nicotine dependence modulates cue-induced brain activity in regions involved in motor preparation and imagery. Psychopharmacology 184: 577-588
24. Joseph AM, Norman SM, Ferry LH et al. (1996) The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. N Engl J Med 335: 1792-1798
25. Jorenby DE, Leischow SJ, Nides MA et al. (1999) A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med 340: 685-691
26. Mann K, Ackermann K, Diehl A et al. (2005) Galantamine: a cholinergic patch in the treatment of alcoholism: a randomized, placebo-controlled trial. Psychopharmacology 184: 115-121
27. Diehl A, Nakovics H, Croissant B et al. (2006) Galantamine reduces smoking in alcohol dependent patients: a randomized, placebo-controlled trial. Int J Clin Pharmacol Ther (in press)
28. Kiefer F, Mann K (2005) New achievements and pharmacotherapeutic approaches in the treatment of alcohol dependence. Eur J Pharmacol 526: 163-171
29. Henningfield JE, Fant RV, Buchhalter AR (2005) Pharmacotherapy for nicotine dependence. CA Cancer J Clin 55: 281-299
30. West R, McNeill A, Raw M (2000) Smoking cessation guidelines for health professionals: an update. Health Education Authority. Thorax 55: 987-999
31. Diehl A, Smolka MN, Mann K (2003) Pharmakotherapie: Rü ckfallprophylaxe bei Alkoholabhängigkeit. Klinikarzt 32: 313-317